PEDMARK® Study in Japan Shows Positive Hearing Loss Results
Fennec Pharmaceuticals reported positive topline results from the investigator-initiated STS-J01 Phase 2/3 study in Japan evaluating Pedmark (sodium thiosulfate)...
AI Drug Discovery AstraZeneca BIO-Europe Spring 2026 biopharma M&A biopharma strategy biotech funding biotech strategy business development cancer immunotherapy China Biotech CNS Pipeline Strategy competitive intelligence Disease-Modifying Therapy Drug Pricing Strategy eClinical Tech News Eli Lilly Emerging Markets FDA Approval FDA Priority Review HER2 Oncology immuno-oncology immunology licensing deals Lifecycle Management Market Access Medtronic MSS colorectal cancer Novo Nordisk Obesity/GLP-1 Obesity Drug Market Obesity Market Oncology Pipeline Patent Cliff Priority Review Voucher pulmonary hypertension Rare Disease Regeneron respiratory biologics Roche Sanofi series A funding Teva Pharmaceuticals Type 1 Diabetes Type 2 Diabetes venture capital
No videos found.
Fennec Pharmaceuticals reported positive topline results from the investigator-initiated STS-J01 Phase 2/3 study in Japan evaluating Pedmark (sodium thiosulfate)...
Dyadic Applied Biosolutions and Brig Bio have signed a development and commercialization agreement to produce recombinant bovine alpha-lactalbumin using...
Syndax Pharmaceuticals will host a fireside chat at the Evercore ISI healthcare conference on December 4, 2025, coming just...
Eli Lilly has launched a tender offer to acquire Adverum Biotechnologies for $3.56 per share in cash plus a...
Nurix Therapeutics will host a webcast on December 8 to review new and updated clinical data from its Phase...
Rakovina Therapeutics reported Q3 2025 results alongside a slate of preclinical updates, highlighting progress across its AI-enabled DNA damage...
At Veeva Commercial Summit Europe, we spoke with Andreas Gerloff, Director of Medical Excellence Operations at Daiichi Sankyo Europe,...
Scilex Holding Company has closed the second tranche of its strategic investment in Datavault AI, funding the purchase of...
HUTCHMED will field a broad slate of oncology and hematology data at ESMO Asia and ASH 2025, spotlighting multiple...
CMS has moved to add catheter ablation for atrial fibrillation to the list of reimbursable procedures in Ambulatory Surgical...
